Nalân Utku
Charite - Universitaetsmedizin Berlin
Campus Virchow-Klinikum
Institut fuer Medizinische Immunologie
Augustenburger Platz 1
Germany
Name/email consistency: high
- Improving the outcomes: developing cancer therapeutics. Utku, N. Future. Oncol (2012)
- Antibody targeting of TIRC7 results in significant therapeutic effects on collagen-induced arthritis in mice. Utku, N., Heinemann, T., Winter, M., Bulwin, C.G., Schlawinsky, M., Fraser, P., Nieuwenhuis, E.E., Volk, H.D., Blumberg, R.S. Clin. Exp. Immunol. (2006)
- TIRC7 pathway as a target for preventing allograft rejection. Tamura, A., Milford, E.L., Utku, N. Drug News Perspect. (2005)
- TIRC7 deficiency causes in vitro and in vivo augmentation of T and B cell activation and cytokine response. Utku, N., Boerner, A., Tomschegg, A., Bennai-Sanfourche, F., Bulwin, G.C., Heinemann, T., Loehler, J., Blumberg, R.S., Volk, H.D. J. Immunol. (2004)
- The human homolog of Drosophila cornichon protein is differentially expressed in alloactivated T-cells. Utku, N., Bulwin, G.C., Beinke, S., Heinemann, T., Beato, F., Randall, J., Schnieders, B., Sandhoff, K., Volk, H.D., Milford, E., Gullans, S.R. Biochim. Biophys. Acta (1999)
- Prevention of acute allograft rejection by antibody targeting of TIRC7, a novel T cell membrane protein. Utku, N., Heinemann, T., Tullius, S.G., Bulwin, G.C., Beinke, S., Blumberg, R.S., Beato, F., Randall, J., Kojima, R., Busconi, L., Robertson, E.S., Schülein, R., Volk, H.D., Milford, E.L., Gullans, S.R. Immunity (1998)
